Department of Obstetrics and Gynecology, Mount Sinai West, 1000 10th Avenue, New York, NY, 10019, USA.
Department of Obstetrics, Gynecology, & Reproductive Medicine, Division of Gynecologic Oncology, Mount Sinai Hospital/Icahn School of Medicine, 1176 Fifth Avenue, New York, NY, 10029, USA.
Curr Treat Options Oncol. 2021 Nov 23;22(12):117. doi: 10.1007/s11864-021-00905-5.
COVID-19 has transformed the care we provide to gynecologic oncology patients. In addition to directly impacting the diagnosis and treatment of women with gynecologic cancer, it has affected our patient's ability to undergo recommended surveillance and has made an impact on every caregiver providing care during this time. Herein we review the current literature on the impact of COVID-19 on gynecologic oncology and highlight new approaches and innovations that have resulted in gynecologic cancer care as a result of the pandemic. The impact of COVID-19 on the field of gynecologic oncology has been profound. In addition to directly impacting the diagnosis and treatment of women with cancer, it has also challenged the very ethics with which we practice medicine. The equitable distribution of resources is paramount to upholding the Hippocratic Oath which we all invoke. The COVID-19 pandemic has stripped this oath down to its very core, forcing all medical practitioners to scrutinize who gets what resources and when. As the pandemic continues to unfold, the question remains - in the setting of a strained and overburdened healthcare system, how do we maximize beneficence to one group of patients, while maintaining non-maleficence to others? As gynecologic oncologists, we are responsible for advocating for our patients to ensure that the quality of their cancer care is not compromised, while also not overutilizing resources that are sorely needed for the care of COVID-19 victims, and not making them more likely to succumb to COVID-19 by the very nature of the treatment we provide. The effects of the pandemic are far-reaching and broad, and many of these are yet to be determined. Future studies are needed to analyze how the above-utilized strategies in GYN cancer care during the pandemic will impact the long-term outcomes of our patients.
COVID-19 改变了我们为妇科肿瘤患者提供的护理方式。它不仅直接影响了妇科癌症患者的诊断和治疗，还影响了她们接受推荐监测的能力，并对在此期间提供护理的每一位医护人员都产生了影响。在此，我们回顾了 COVID-19 对妇科肿瘤学的影响，并强调了由于大流行而导致的妇科癌症护理方面的新方法和创新。COVID-19 对妇科肿瘤学领域的影响是深远的。它不仅直接影响了癌症女性的诊断和治疗，还对我们行医的道德规范提出了挑战。公平分配资源对于维护我们都援引的希波克拉底誓言至关重要。COVID-19 大流行将这一誓言简化为其核心内容，迫使所有医疗从业者仔细审查谁得到什么资源以及何时得到。随着大流行的继续发展，问题仍然存在——在医疗系统紧张和负担过重的情况下，我们如何最大限度地为一群患者带来益处，同时保持对其他人的非伤害？作为妇科肿瘤学家，我们有责任为我们的患者辩护，以确保他们的癌症护理质量不受影响，同时也不过度利用本应为 COVID-19 患者提供护理的急需资源，并且不会因为我们提供的治疗本身而使他们更容易感染 COVID-19。大流行的影响是深远而广泛的，其中许多影响尚未确定。需要进一步的研究来分析大流行期间妇科癌症护理中上述策略的利用将如何影响我们患者的长期预后。
